| Literature DB >> 30791679 |
Jacob Hjelmborg1,2, Pia Larsen3, Jaakko Kaprio4, Matt McGue5,6, Thomas Scheike7, Philip Hougaard5,8, Kaare Christensen9,10.
Abstract
Studies with twins provide fundamental insights to lifespans of humans. We aim to clarify if monozygotic and dizygotic twin individuals differ in lifespan, that is, if zygosity matters. We investigate whether a possible difference in mortality after infancy between zygosities is stable in different age cohorts, and whether the difference remains when twins with unknown zygosity are taken into account. Further, we compare the distribution of long-livers, that is, the upper-tail of the lifespan distribution, between monozygotic and same-sex dizygotic twin individuals. The Danish Twin Registry provides a nationwide cohort of 109,303 twins born during 1870 to 1990 with valid vital status. Standard survival analysis is used to compare mortality in monozygotic and dizygotic twin individuals and twin individuals with unknown zygosity. The mortality of monozygotic and dizygotic twin individuals differs slightly after taking into consideration effects of birth- and age-cohorts, gender differences, and that twins are paired. However, no substantial nor systematic differences remain when taking twins with unknown zygosity into account. Further, the distribution of long-livers is very similar by zygosity, suggesting the same mortality process. The population-based and oldest twin cohort ever studied suggests that monozygotic and dizygotic twins have similar lifespans.Entities:
Keywords: age-stratification; cumulative incidence curves; lifespan; long-livers; mortality; twins; unknown zygosity; zygosity
Mesh:
Year: 2019 PMID: 30791679 PMCID: PMC6409769 DOI: 10.3390/genes10020166
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Flowchart.
Population characteristics of individual twins, surviving to age 6, in the four cohorts, excluding UZ.
| All cohorts | Cohort 1 | Cohort 2 | Cohort 3 | Cohort 4 | |
|---|---|---|---|---|---|
| Total, | 96,338 (49,390) | 9037 (4907) | 15,645 (8060) | 37,330 (19,114) | 34,326 (17,309) |
| Age at FU a, mean (SD) | 58.5 (18.3) | 69.0 (19.8) | 74.0 (16.8) | 65.3 (11.2) | 41.2 (9.2) |
| Sex, | |||||
| Male | 49,100 (51.0) | 4496 (49.8) | 7480 (47.8) | 20,133 (53.9) | 16,991 (49.5) |
| Female | 47,238 (49.0) | 4541 (50.3) | 8165 (52.2) | 17,197 (46.1) | 17,335 (50.5) |
| Zygosity, | |||||
| MZ | 23,888 (24.8) | 2247 (24.9) | 4613 (29.5) | 7122 (19.1) | 9906 (28.9) |
| SSDZ | 39,728 (41.2) | 4029 (44.6) | 9156 (58.5) | 14,440 (38.9) | 12,103 (35.3) |
| OSDZ | 32,722 (34.0) | 2761 (30.6) | 1876 (12.0) | 15,768 (42.2) | 12,317 (35.9) |
| Dead during FU a, | |||||
| No/censored | 62,459 (64.8) | 208 (2.3) | 959 (6.1) | 27,806 (74.5) | 33,486 (97.6) |
| Yes | 33,879 (35.2) | 8829 (97.7) | 14,686 (93.9) | 9524 (25.5) | 840 (2.4) |
a FU is defined as time until death, censoring (emigration) or end of study period (1 October 2016). SD: standard deviation; MZ: monozygotic; SSDZ: same-sex dizygotic; OSDZ: opposite-sex dizygotic.
Associations between mortality and zygosity in individual twins from all birth cohorts 1870–1990 and surviving to age 6; among individual twins at ages up to 50 years, between 50–75 years, and from 75 years.
| All Ages, | Ages ≤50, | Ages 51–75, | Ages >75, | |
|---|---|---|---|---|
|
| HR (95%-CI) | HR (95%-CI) | HR (95%-CI) | HR (95%-CI) |
| Zygosity, | ||||
| MZ | Ref. | Ref. | Ref. | Ref. |
| SSDZ | 1.09 (1.06, 1.12) *** | 1.19 (1.11, 1.29) *** | 1.11 (1.06, 1.17) *** | 1.04 (1.00, 1.09) * |
| OSDZ | 1.17 (1.13, 1.21) *** | 1.53 (1.41, 1.66) *** | 1.12 (1.06, 1.18) *** | 1.09 (1.04, 1.15) *** |
|
| ||||
| Zygosity, | ||||
| MZ | Ref. | Ref. | Ref. | Ref. |
| SSDZ | 1.11 (1.07, 1.16) *** | 1.23 (1.11, 1.36) *** | 1.11 (1.04, 1.18) *** | 1.07 (1.00, 1.13) * |
| OSDZ | 1.16 (1.11, 1.21) *** | 1.44 (1.30, 1.60) *** | 1.10 (1.03, 1.18) ** | 1.11 (1.03, 1.19) ** |
|
| ||||
| Zygosity, | ||||
| MZ | Ref. | Ref. | Ref. | Ref. |
| SSDZ | 1.07 (1.03, 1.12) ** | 1.20 (1.11, 1.30) *** | 1.12 (1.07, 1.17) *** | 1.04 (1.00, 1.08) |
| OSDZ | 1.18 (1.13, 1.24) *** | 1.52 (1.40, 1.64) *** | 1.11 (1.06, 1.17) *** | 1.09 (1.04, 1.15) *** |
a Baseline hazard stratified on cohort group (analyses on both sexes stratified on sex as well). HR: hazard ratio; CI: confidence interval; * p < 0.05, ** p < 0.01, *** p < 0.001.
Population characteristics of individual twins, surviving to age 6, birth cohorts 1961–1990.
| All Subjects | Males | Females | |
|---|---|---|---|
| Total, | 39,504 (20,232) | 19,964 (13,266) | 19,540 (13,000) |
| Age at FU a, mean (SD) | 40.3 (9.6) | 40.2 (9.5) | 40.5 (9.6) |
| Sex, | |||
| Male | 19,964 (50.5) | 19,964 (100.0) | - |
| Female | 19,540 (49.5) | - | 19,540 (100.0) |
| Zygosity, | |||
| MZ | 9906 (25.1) | 4689 (23.5) | 5217 (26.7) |
| SSDZ | 12,103 (30.6) | 6159 (30.9) | 5944 (30.4) |
| OSDZ | 12,317 (31.2) | 6143 (30.8) | 6174 (31.6) |
| UZ | 5178 (13.1) | 2973 (14.9) | 2205 (11.3) |
| Dead during FU a, | |||
| No | 38,519 (97.5) | 19,334 (96.8) | 19,185 (98.2) |
| Yes | 985 (2.5) | 630 (3.2) | 355 (1.8) |
a FU is defined as time until death, censoring (emigration) or end of study period (1 October 2016).
Associations between mortality and zygosity in individual twins, birth cohorts 1961–1990, surviving to age 6; among individual twins at ages up to 50 years, and from 50 years.
| All Ages, | Ages ≤50, | Ages >50, | |
|---|---|---|---|
|
| HR (95%-CI) | HR (95%-CI) | HR (95%-CI) |
| Zygosity | |||
| MZ | Ref. | Ref. | Ref. |
| SSDZ | 1.07 (0.89, 1.13) | 1.10 (0.91, 1.34) | 0.80 (0.46, 1.40) |
| OSDZ | 1.21 (1.01, 1.45) * | 1.23 (1.02, 1.48) * | 1.05 (0.61, 1.79) |
| UZ | 1.83 (1.47, 2.28) *** | 1.89 (1.51, 2.37) *** | 1.25 (0.49, 3.20) |
|
| |||
| Zygosity | |||
| MZ | Ref. | Ref. | Ref. |
| SSDZ | 1.01 (0.80, 1.28) | 1.06 (0.83, 1.35) | 0.63 (0.29, 1.37) |
| OSDZ | 1.22 (0.97, 1.53) | 1.23 (0.97, 1.55) | 1.14 (0.56, 2.29) |
| UZ | 1.86 (1.43, 2.42) *** | 1.92 (1.46, 2.51) *** | 1.26 (0.39, 4.11) |
|
| |||
| Zygosity | |||
| MZ | Ref. | Ref. | Ref. |
| SSDZ | 1.17 (0.88, 1.56) | 1.19 (0.88, 1.62) | 1.04 (0.46, 2.31) |
| OSDZ | 1.19 (0.90, 1.58) | 1.23 (0.91, 1.67) | 1.14 (0.56, 2.28) |
| UZ | 1.71 (1.13, 2.60) * | 1.78 (1.15, 2.75) ** | 1.18 (0.26, 5.45) |
a Baseline hazard stratified on sex. * p < 0.05, ** p < 0.01, *** p < 0.001.